Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $17.87 in the prior trading day, Axogen Inc (NASDAQ: AXGN) closed at $17.88, up 0.06%. In other words, the price has increased by $0.06 from its previous closing price. On the day, 1.72 million shares were traded. AXGN stock price reached its highest trading level at $18.04 during the session, while it also had its lowest trading level at $17.14.
Ratios:
Our goal is to gain a better understanding of AXGN by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 22.90 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 166.54. For the most recent quarter (mrq), Quick Ratio is recorded 2.67 and its Current Ratio is at 4.14. In the meantime, Its Debt-to-Equity ratio is 0.61 whereas as Long-Term Debt/Eq ratio is at 0.59.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Lake Street on March 17, 2025, initiated with a Buy rating and assigned the stock a target price of $30. On July 01, 2024, Raymond James started tracking the stock assigning a Outperform rating and target price of $13.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 02 ’25 when Burke William P. Mr. bought 2,400 shares for $18.01 per share.
WILLIAM BURKE bought 7,620 shares of AXGN for $136,169 on Oct 02 ’25. On Sep 16 ’25, another insider, DeVinney Erick Wayne, who serves as the Chief Innovation Officer of the company, sold 1,137 shares for $16.29 each. As a result, the insider received 18,522 and left with 220,649 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AXGN now has a Market Capitalization of 822704832 and an Enterprise Value of 863048832. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.05 while its Price-to-Book (P/B) ratio in mrq is 7.29. Its current Enterprise Value per Revenue stands at 4.246 whereas that against EBITDA is 99.786.
Stock Price History:
The Beta on a monthly basis for AXGN is 1.07, which has changed by 0.30797362 over the last 52 weeks, in comparison to a change of 0.16766965 over the same period for the S&P500. Over the past 52 weeks, AXGN has reached a high of $21.00, while it has fallen to a 52-week low of $9.22. The 50-Day Moving Average of the stock is 15.09%, while the 200-Day Moving Average is calculated to be 17.35%.
Shares Statistics:
The stock has traded on average 1.32M shares per day over the past 3-months and 956820 shares per day over the last 10 days, according to various share statistics. A total of 45.77M shares are outstanding, with a floating share count of 43.53M. Insiders hold about 5.40% of the company’s shares, while institutions hold 87.85% stake in the company. Shares short for AXGN as of 1757894400 were 2476701 with a Short Ratio of 1.87, compared to 1755216000 on 3053163. Therefore, it implies a Short% of Shares Outstanding of 2476701 and a Short% of Float of 5.54.
Earnings Estimates
Investors are keenly observing as 5.0 analysts analyze and rate. The current performance of Axogen Inc (AXGN) in the stock market.The consensus estimate for the next quarter is $0.09, with high estimates of $0.13 and low estimates of $0.06.
Analysts are recommending an EPS of between $0.37 and $0.21 for the fiscal current year, implying an average EPS of $0.26. EPS for the following year is $0.47, with 5.0 analysts recommending between $0.6 and $0.41.
Revenue Estimates
8 analysts predict $56.9M in revenue for. The current quarter. It ranges from a high estimate of $57.2M to a low estimate of $56M. As of. The current estimate, Axogen Inc’s year-ago sales were $48.64MFor the next quarter, 8 analysts are estimating revenue of $57.54M. There is a high estimate of $57.9M for the next quarter, whereas the lowest estimate is $57M.
A total of 8 analysts have provided revenue estimates for AXGN’s current fiscal year. The highest revenue estimate was $220.3M, while the lowest revenue estimate was $219M, resulting in an average revenue estimate of $219.63M. In the same quarter a year ago, actual revenue was $187.34MBased on 8 analysts’ estimates, the company’s revenue will be $254.05M in the next fiscal year. The high estimate is $260M and the low estimate is $249.7M.
